Log in or Sign up for Free to view tailored content for your specialty!
Hepatology News
Risk for heart, liver disease may vary between PCOS subtypes
Women with polycystic ovary syndrome and high androgen levels may have a higher risk for liver disease than those with PCOS and normal androgen levels, according to an analysis of UK Biobank data.
Fazirsiran lowers serum, liver concentrations of Z-AAT in alpha-1 antitrypsin deficiency
In a dose-dependent manner, fazirsiran reduced serum and liver concentrations of Z-AAT and also improved histological measures in patients with homozygous ZZ alpha-1 antitrypsin deficiency-associated liver disease, according to data.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Toolkit supports access to mental health care for health care workers
NEW YORK — In this Healio Video Perspective from the American Psychiatric Association Annual Meeting, Stefanie Simmons, MD, FACEP, chief medical officer of the Dr. Lorna Breen Heroes’ Foundation, discusses the Frontline Connect toolkit.
Student loans: Let’s talk about SAVE
The Savings on a Valuable Education (SAVE) plan was introduced in 2023 by the Biden Administration and replaces the Revised Pay As You Earn (REPAYE) program. SAVE continues to evolve with new benefits for student loan borrowers.
Tenofovir alafenamide maintains virological control in HBV with renal, hepatic impairment
Tenofovir alafenamide was safe and maintained virological response in patients with chronic hepatitis B virus infection and renal or hepatic impairment who switched from tenofovir disoproxil fumarate or other antivirals, according to data.
‘Even one meal change’ to vegetarian, vegan can reduce serum ammonia in cirrhosis
Substitution of just one meat-based meal with a vegetarian or vegan alternative reduced serum ammonia levels for up to 3 hours and improved metabolites in patients with cirrhosis who follow a Western meat-based diet, researchers reported.
U.S. News & World Report announces 2024-2025 best hospitals
U.S. News & World Report announced its 2024-2025 Best Hospitals rankings Tuesday.
VIDEO: GLP-1 use for MASH is ‘not black and white’; best approach may lie in the gray
In a Healio video exclusive, Edward V. Loftus Jr., MD, noted that, despite the boom in glucagon-like peptide-1 agonists for diabetes and weight loss, its role in the treatment of liver disease is still up for debate.
‘Highly plausible’ GLP-1s can improve health-related QoL, economic burden of MASH
Metabolic dysfunction-associated steatotic liver disease affects more than one-third of the world’s population and is associated with significant clinical and economic burden, as well as impairment of health-related quality of life.
‘Whether or not we like it,’ GLP-1s are part of hepatology, treatment of MASH
To put it simply, diabetes and steatotic liver disease are joined at the hip. They are part of the same biological process that involves multiple organs, connected by the concept of metabolic flexibility — or lack thereof.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read